The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Sampling Variability of Liver Fibrosis in Chronic Hepatitis C
Abstract
Fibrosis is a common endpoint of clinical trials in chronic hepatitis C, and liver biopsy remains the gold standard for fibrosis evaluation. However, variability in the distribution of fibrosis within the liver is a potential limitation. Our aim was to assess the heterogeneity of liver fibrosis and its influence on the accuracy of assessment of fibrosis with liver biopsy. Surgical samples of livers from patients with chronic hepatitis C were studied. Measurement of fibrosis was performed on the whole section by using both image analysis and METAVIR score (reference value). From the digitized image of the whole section, virtual biopsy specimens of increasing length were produced. Fibrosis was assessed independently on each individual virtual biopsy specimen. Results were compared with the reference value according to the length of the biopsy specimen. By using image analysis, the coefficient of variation of fibrosis measurement with 15–mm long biopsy specimens was 55%; and for biopsy specimens of 25–mm length it was 45%. By using the METAVIR scoring system, 65% of biopsies 15 mm in length were categorized correctly according to the reference value. This increased to 75% for a 25–mm liver biopsy specimen without any substantial benefit for longer biopsy specimens. Sampling variability of fibrosis is a significant limitation in the assessment of fibrosis with liver biopsy. In conclusion, this study suggests that a length of at least 25 mm is necessary to evaluate fibrosis accurately with a semiquantitative score. Sampling variability becomes a major limitation when using more accurate methods such as automated image analysis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Natural history of liver fibrosis progression in patients with chronic hepatitis C
Poynard, T., Bedossa, P., & Opolon, P. (1997) · The Lancet · doi:10.1016/s0140-6736(96)07642-8 · Cited by 3,011
Rates and risk factors of liver fibrosis progression in patients with chronic hepatitis c
Poynard, T., Ratziu, V., Charlotte, F., Goodman, Z., McHutchison, J., & Albrecht, J. (2001) · Journal of Hepatology · doi:10.1016/s0168-8278(00)00097-0 · Cited by 749
Research works printed but not linked: 33
- Desmet, 1994, Hepatology, 19, 1513, 10.1002/hep.1840190629 · DOI · Paper page
- Gebo, 2002, Hepatology, 36, s161, 10.1002/hep.1840360721 · DOI
- Saadeh, 2001, Hepatology, 33, 196, 10.1053/jhep.2001.20534 · DOI · Paper page
- Bedossa, 1994, Hepatology, 20, 15, 10.1002/hep.1840200104 · DOI
- Westin, 1999, Liver, 19, 183, 10.1111/j.1478-3231.1999.tb00033.x · DOI
- Gascon-Barre, 1989, J Histochem Cytochem, 37, 3, 10.1177/37.3.2465335 · DOI
- Soloway, 1971, Am J Dig Dis, 16, 1082, 10.1007/BF02235164 · DOI · Paper page
- Knodell, 1981, Hepatology, 1, 431, 10.1002/hep.1840010511 · DOI
- Bedossa, 1996, Hepatology, 24, 289, 10.1002/hep.510240201 · DOI · Paper page
- Chevallier, 1994, Hepatology, 20, 349, 10.1002/hep.1840200213 · DOI · Paper page
- Ishak, 1995, J Hepatol, 22, 696, 10.1016/0168-8278(95)80226-6 · DOI
- Pilette, 1998, J Hepatol, 27, 1, 10.1002/hep.510270101 · DOI
- Ryoo, 1989, Mod Pathol, 2, 382
- Lin, 1998, J Gastroenterol Hepatol, 13, 75, 10.1111/j.1440-1746.1998.tb00549.x · DOI
- Masseroli, 2000, J Hepatol, 32, 453, 10.1016/S0168-8278(00)80397-9 · DOI
- Kage, 1997, Hepatology, 25, 1028, 10.1002/hep.510250439 · DOI
- Moal, 2002, Hepatology, 36, 840, 10.1053/jhep.2002.35533 · DOI
- Caballero, 2001, J Hepatol, 34, 740, 10.1016/S0168-8278(01)00006-X · DOI
- Fort, 1998, Hepatology, 28, 1525, 10.1002/hep.510280612 · DOI
- Poynard, 2000, Semin Liver Dis, 20, 47, 10.1055/s-2000-9258 · DOI
- Layden, 1979, Arch Intern Med, 139, 856, 10.1001/archinte.1979.03630450010005 · DOI
- Abdi, 1979, Arch Intern Med, 139, 667, 10.1001/archinte.1979.03630430043014 · DOI · Paper page
- Maharaj, 1986, Lancet, 1, 523, 10.1016/S0140-6736(86)90883-4 · DOI · Paper page
- Baunsgaard, 1979, Acta Pathol Microbiol Scand, 87, 21
- Hohlund, 1980, Scand J Gastroenterol, 15, 329, 10.3109/00365528009181479 · DOI
- Feldmann, 1995, J Hepatol, 22, 49, 10.1016/0270-9139(95)94111-8 · DOI
- Ishak, 1995, J Hepatol, 22, 696, 10.1016/0168-8278(95)80226-6 · DOI
- Fontana, 2002, Hepatology, 36, s57, 10.1002/hep.1840360708 · DOI
- Hirata, 2001, Eur J Clin Invest, 31, 528, 10.1046/j.1365-2362.2001.00840.x · DOI
- Oberti, 1997, Gastroenterology, 113, 1609, 10.1053/gast.1997.v113.pm9352863 · DOI
- Cho, 2001, Radiology, 221, 740, 10.1148/radiol.2213010106 · DOI
- Afdhal, 2003, Hepatology, 37, 972, 10.1053/jhep.2003.50223 · DOI
- Forns, 2002, Hepatology, 36, 986, 10.1053/jhep.2002.36128 · DOI · Paper page
Cited by
Sterling, R. K., Lissen, E., Clumeck, N., Sola, R., Correa, M. C., Montaner, J., S. Sulkowski, M., Torriani, F. J., Dieterich, D. T., Thomas, D. L., et al. (2006) · Hepatology · doi:10.1002/hep.21178 · Cited by 5,021
Sampling Variability of Liver Biopsy in Nonalcoholic Fatty Liver Disease
Ratziu, V., Charlotte, F., Heurtier, A., Gombert, S., Giral, P., Bruckert, E., Grimaldi, A., Capron, F., & Poynard, T. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.03.084 · Cited by 2,106
Schuppan, D., & Afdhal, N. H. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60383-9 · Cited by 2,089
Berzigotti, A., Tsochatzis, E., Boursier, J., Castera, L., Cazzagon, N., Friedrich-Rust, M., Petta, S., & Thiele, M. (2021) · Journal of Hepatology · doi:10.1016/j.jhep.2021.05.025 · Cited by 1,925
(2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.04.006 · Cited by 1,875
Marcellin, P., Gane, E., Buti, M., Afdhal, N., Sievert, W., Jacobson, I. M., Washington, M. K., Germanidis, G., Flaherty, J. F., Schall, R. A., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(12)61425-1 · Cited by 1,788
Xiao, G., Zhu, S., Xiao, X., Yan, L., Yang, J., & Wu, G. (2017) · Hepatology · doi:10.1002/hep.29302 · Cited by 895
Extrahepatic cholestasis increases liver stiffness (FibroScan) irrespective of fibrosis
Millonig, G., Reimann, F. M., Friedrich, S., Fonouni, H., Mehrabi, A., Büchler, M. W., Seitz, H. K., & Mueller, S. (2008) · Hepatology · doi:10.1002/hep.22577 · Cited by 599
Spatial heterogeneity in the mammalian liver
Ben-Moshe, S., & Itzkovitz, S. (2019) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0134-x · Cited by 485
Neuberger, J., Patel, J., Caldwell, H., Davies, S., Hebditch, V., Hollywood, C., Hubscher, S., Karkhanis, S., Lester, W., Roslund, N., et al. (2020) · Gut · doi:10.1136/gutjnl-2020-321299 · Cited by 449
Liver stiffness: a novel parameter for the diagnosis of liver disease
Mueller, S. (2010) · Hepatic Medicine: Evidence and Research · doi:10.2147/hmer.s7394 · Cited by 434
Clinical evidence for the regression of liver fibrosis
Ellis, E. L., & Mann, D. A. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2011.09.024 · Cited by 411
D'Ambrosio, R., Aghemo, A., Rumi, M. G., Ronchi, G., Donato, M. F., Paradis, V., Colombo, M., & Bedossa, P. (2012) · Hepatology · doi:10.1002/hep.25606 · Cited by 409
Self-citationHepatic fibrosis: molecular mechanisms and drug targets
Lotersztajn, S., Julien, B., Teixeira-Clerc, F., Grenard, P., & Mallat, A. (2005) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.45.120403.095906 · Cited by 325
Kleiner, D. E., & Makhlouf, H. R. (2016) · Clinics in Liver Disease · doi:10.1016/j.cld.2015.10.011 · Cited by 303
CCL2-dependent infiltrating macrophages promote angiogenesis in progressive liver fibrosis
Ehling, J., Bartneck, M., Wei, X., Gremse, F., Fech, V., Möckel, D., Baeck, C., Hittatiya, K., Eulberg, D., Luedde, T., et al. (2014) · Gut · doi:10.1136/gutjnl-2013-306294 · Cited by 273
Impact of non-invasive biomarkers on hepatology practice: past, present and future
Anstee, Q. M., Castera, L., & Loomba, R. (2022) · Journal of Hepatology · doi:10.1016/j.jhep.2022.03.026 · Cited by 224
Prediction of clinical outcomes in primary biliary cirrhosis by serum enhanced liver fibrosis assay
Mayo, M. J., Parkes, J., Adams-Huet, B., Combes, B., Mills, A. S., Markin, R. S., Rubin, R., Wheeler, D., Contos, M., West, A. B., et al. (2008) · Hepatology · doi:10.1002/hep.22517 · Cited by 198
Enhanced liver fibrosis score predicts transplant-free survival in primary sclerosing cholangitis
Vesterhus, M., Hov, J. R., Holm, A., Schrumpf, E., Nygård, S., Godang, K., Andersen, I. M., Næss, S., Thorburn, D., Saffioti, F., et al. (2015) · Hepatology · doi:10.1002/hep.27825 · Cited by 138
Repeatability and reproducibility of multiparametric magnetic resonance imaging of the liver
Bachtiar, V., Kelly, M. D., Wilman, H. R., Jacobs, J., Newbould, R., Kelly, C. J., Gyngell, M. L., Groves, K. E., McKay, A., Herlihy, A. H., et al. (2019) · PLOS ONE · doi:10.1371/journal.pone.0214921 · Cited by 117
Vilar-Gomez, E., Lou, Z., Kong, N., Vuppalanchi, R., Imperiale, T. F., & Chalasani, N. (2020) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2020.04.017 · Cited by 75
A critical review of endpoints for non-cirrhotic NASH therapeutic trials
Ratziu, V. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2017.12.001 · Cited by 74
Porcine liver anatomy applied to biomedicine
Eberlova, L., Maleckova, A., Mik, P., Tonar, Z., Jirik, M., Mirka, H., Palek, R., Leupen, S., & Liska, V. (2020) · Journal of Surgical Research · doi:10.1016/j.jss.2019.12.038 · Cited by 45
Wang, Y., Wong, G. L.-H., He, F.-P., Sun, J., Chan, A. W.-H., Yang, J., Shu, S. S.-T., Liang, X., Tse, Y. K., Fan, X.-T., et al. (2020) · Gut · doi:10.1136/gutjnl-2019-318841 · Cited by 42
Stift, J., Semmler, G., Walzel, C., Mandorfer, M., Schwarzer, R., Schwabl, P., Paternostro, R., Scheiner, B., Wöran, K., Pinter, M., et al. (2019) · Digestive and Liver Disease · doi:10.1016/j.dld.2019.01.020 · Cited by 34
Rosato, V., Ascione, A., Nevola, R., Fracanzani, A. L., Piai, G., Messina, V., Claar, E., Coppola, C., Fontanella, L., Lombardi, R., et al. (2022) · Journal of Viral Hepatitis · doi:10.1111/jvh.13617 · Cited by 17
Stift, J., Semmler, G., Wöran, K., Simbrunner, B., Scheiner, B., Schwabl, P., Paternostro, R., Pinter, M., Stättermayer, A. F., Meischl, T., et al. (2020) · Digestive and Liver Disease · doi:10.1016/j.dld.2020.08.028 · Cited by 16
The Effect of Laparoscopic Sleeve Gastrectomy on Nonalcoholic Fatty Liver Disease
Batman, B., Altun, H., Simsek, B., Aslan, E., & Namli Koc, S. (2019) · Surgical Laparoscopy, Endoscopy & Percutaneous Techniques · doi:10.1097/sle.0000000000000672 · Cited by 9
Yang, L., Zhang, Y., Hong, X., Zhang, K., Liu, B., Zhang, P., Tang, Q., Yu, J., Jin, X.-Z., Jin, X.-Z., et al. (2024) · BMC Medicine · doi:10.1186/s12916-024-03502-z · Cited by 7
Metadata
- Authors
- Bedossa, P., Dargère, D., & Paradis, V.
- Venue
- Hepatology
- Published
- 2003-12
- Volume
- 38
- Issue
- 6
- Pages
- 1449-1457
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W2013716066
- Cited by
- 2,376
- References
- 2
- FWCI
- 45.29
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- doi.wiley.com/10.1002/tdm_license_1.1 (tdm, 4292 d)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.